MEI Pharma, Inc. (MEIP)
NASDAQ: MEIP · Real-Time Price · USD
6.55
+0.63 (10.64%)
At close: Jul 21, 2025, 4:00 PM
6.50
-0.05 (-0.76%)
After-hours: Jul 21, 2025, 7:57 PM EDT

MEI Pharma Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for MEI Pharma.

Price Target: n/a
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

According to 1 stock analyst, the rating for MEI Pharma is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingFeb '24Mar '24Apr '24May '24Jun '24Jul '24
Strong Buy111110
Buy000000
Hold111111
Sell000000
Strong Sell000000
Total222221

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Laidlaw & Co.
Laidlaw & Co.
Hold
Downgrades
n/a
HoldDowngradesn/an/aJul 23, 2024
Stifel
Stifel
Hold
Maintains
$7
HoldMaintains$7+6.87%Apr 12, 2024
Stifel
Stifel
Hold
Maintains
$8$7
HoldMaintains$8$7+6.87%Feb 14, 2024
Stifel
Stifel
Hold
Maintains
$10$9
HoldMaintains$10$9+37.40%Sep 27, 2023
Brookline Capital
Brookline Capital
Strong Buy
Maintains
$80
Strong BuyMaintains$80+1,121.37%May 23, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 65.30M
Revenue Next Year
25.50M
EPS This Year
-6.41
from 2.67
EPS Next Year
-3.78
from -6.41
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2020Jun 30, 2021Jun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
27.76M34.80M40.70M48.82M65.30M-25.50M25.50M
Revenue Growth
464.72%25.36%16.96%19.95%33.76%---
EPS
-10.36-12.00-9.99-4.782.67-6.41-3.78-1.59
EPS Growth
--------
Forward PE
--------
No. Analysts
-----344
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
Highn/a26.3M26.3M
Avgn/a25.5M25.5M
Lown/a24.5M24.5M

Revenue Growth

Revenue Growth202520262027
High--
2.9%
Avg---
Low--
-3.9%

EPS Forecast

EPS202520262027
High-6.59-3.90-1.64
Avg-6.41-3.78-1.59
Low-6.15-3.64-1.53

EPS Growth

EPS Growth202520262027
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.